1. Home
  2. PTGX vs SHO Comparison

PTGX vs SHO Comparison

Compare PTGX & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

SELL

Current Price

$129.57

Market Cap

9.3B

Sector

Health Care

ML Signal

SELL

Logo Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SELL

Current Price

$11.91

Market Cap

2.0B

ML Signal

SELL

Company Overview

Basic Information
Metric
PTGX
SHO
Founded
2006
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
2.0B
IPO Year
2016
2004

Fundamental Metrics

Financial Performance
Metric
PTGX
SHO
Price
$129.57
$11.91
Analyst Decision
Strong Buy
Buy
Analyst Count
14
12
Target Price
★ $178.21
$12.04
AVG Volume (30 Days)
761.5K
★ 1.7M
Earning Date
11-05-2026
11-06-2026
Dividend Yield
N/A
★ 3.03%
EPS Growth
N/A
★ N/A
EPS
★ 2.35
0.22
Revenue
N/A
★ $1,115,167,000.00
Revenue This Year
$1,077.07
$2.49
Revenue Next Year
N/A
N/A
P/E Ratio
$58.11
★ $53.95
Revenue Growth
★ N/A
N/A
52 Week Low
$73.08
$8.69
52 Week High
$160.81
$12.07

Technical Indicators

Market Signals
Indicator
PTGX
SHO
Relative Strength Index (RSI) 32.76 70.46
Support Level $127.98 $10.95
Resistance Level $142.20 $12.01
Average True Range (ATR) 5.65 0.26
MACD -0.76 0.07
Stochastic Oscillator 14.46 63.60

Price Performance

Historical Comparison
PTGX
SHO

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

Share on Social Networks: